Robert Ehrlich has joined the strategic advisory board at Dialyze Direct, a company now operating in close to a dozen states, in approximately 100 skilled-nursing facilities. Having served for a decade as chairman and CEO of Fresenius, Ehrlich brings knowledge of the dialysis industry and its history. The company’s initial focus in the home dialysis market is on skilled-nursing facilities (SNFs), in which many of the most medically challenging subset of dialysis patients reside.
Dialyze Direct’s team implements personalized plans of care in coordination with a patient’s primary medical team. This gentler five-day treatment plan (pursuant to physicians’ orders) consists of protocols and procedures, which specifically tackle the unique fluid management challenges of geriatric dialysis patients, resulting in increased overall patient health and reduced hospitalizations.
